Page last updated: 2024-08-17

carbostyril and Carcinoma, Medullary

carbostyril has been researched along with Carcinoma, Medullary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chintala, L; El Naggar, AK; Gagel, R; Hong, D; Kurzrock, R; Wright, J; Ye, L1

Other Studies

1 other study(ies) available for carbostyril and Carcinoma, Medullary

ArticleYear
Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:5

    Topics: Adult; Amino Acid Sequence; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Medullary; Cell Line, Tumor; Exons; Humans; Male; Molecular Sequence Data; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Pyridines; Quinolones; Sorafenib; Thyroid Neoplasms

2008